Lv6
2510 积分 2024-07-23 加入
Antitumor Cytotoxic Activity Retained in Tolerized T Cells Following Daily Dose Escalation of a T-Cell Engager in Cynomolgus Monkeys to Mitigate Cytokine Release Syndrome
1个月前
已完结
A bispecific CD3×CD19 antibody for systemic lupus erythematosus: a phase 1 trial. Nat Med (2026)
1个月前
已完结
Safety and Efficacy of a-319 (a CD3xCD19 T cell engager) in Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma
1个月前
已完结
A bispecific CD3×CD19 antibody for systemic lupus erythematosus: a phase 1 trial
1个月前
已完结
Design and preclinical characterization of an affinity-tuned BCMA×CD3 bispecific T-cell engager for broad B-cell depletion
1个月前
已完结
Swiss S1 Guidelines for the Management of Hidradenitis Suppurativa
1个月前
已完结
TL1A Promotes Lung Tissue Fibrosis and Airway Remodeling Get access Arrow
2个月前
已完结
Navigating evidence-based recommendations for the management of systemic sclerosis
2个月前
已完结
中国系统性硬化症诊治指南（2026版）
2个月前
已完结
Safety and efficacy of the anti-TL1A monoclonal antibody tulisokibart for Crohn's disease: a phase 2a induction trial
2个月前
已完结
皖公网安备34019202002308
